HSV-2 is one of two types of herpes simplex virus, and it is the primary cause of genital herpes. It spreads through sexual skin-to-skin contact, settles permanently into nerve cells near the base of the spine, and reactivates periodically to cause outbreaks of painful blisters in the genital area. Most people with HSV-2 have mild or unrecognizable symptoms, which is a major reason it spreads so easily.
How HSV-2 Infects the Body
When HSV-2 first enters the body, it infects cells in the skin or mucous membranes at the site of contact. The virus replicates there, sometimes causing visible sores, then travels along nerve fibers to clusters of nerve cells called ganglia near the spinal cord. Once it reaches those neurons, it goes dormant. This dormant state, called latency, is what makes herpes a lifelong infection. The virus essentially hides inside nerve cells where the immune system can’t reach it.
Periodically, the virus “wakes up” and travels back down the nerve fibers to the skin’s surface. These reactivation episodes can produce a visible outbreak of blisters, or the virus can reach the skin surface without causing any noticeable symptoms at all. Either way, the virus is present on the skin and can be transmitted to a partner. These bursts of activity at the skin surface are brief, typically lasting only two to six hours before subsiding.
How HSV-2 Spreads
HSV-2 transmits through direct skin-to-skin contact during sex, almost exclusively through genital-to-genital contact. Oral-to-genital transmission of HSV-2 is rare. This is one of the key differences from HSV-1, which spreads readily through oral contact and can cause genital infections through oral sex.
What makes HSV-2 particularly efficient at spreading is asymptomatic shedding, periods when the virus is active on the skin with no visible sores or symptoms. In one study, 70% of new HSV-2 transmissions were traced to sexual contact during these invisible shedding periods. Asymptomatic shedding is most frequent in the first year after infection and becomes less common over time, though it never stops entirely.
Symptoms and Outbreaks
The first outbreak of genital HSV-2 is usually the worst. In the 48 hours before blisters appear, many people experience what’s called a prodrome: fever, headache, swollen lymph nodes, and itching or tingling in the genital area. Some people also feel shooting pains in the buttocks, legs, or groin. Then fluid-filled blisters develop on or around the genitals, eventually breaking open, crusting over, and healing. The incubation period from initial infection to first symptoms ranges from one to 26 days, but six to eight days is typical.
Recurrent outbreaks are shorter and less severe than the first one. Over time, most people experience fewer and fewer outbreaks per year. HSV-2 is much more likely to cause frequent recurrences than genital HSV-1 infection, which often produces only one or two outbreaks before going quiet for good. This recurrence pattern is one of the most meaningful clinical differences between the two virus types.
Many people with HSV-2 never have a recognizable outbreak. They carry the virus, shed it intermittently, and can pass it to partners without ever knowing they’re infected.
HSV-1 vs. HSV-2
Both viruses belong to the same family and cause similar-looking sores, but they differ in where they prefer to live and how often they reactivate. HSV-1 primarily infects the mouth and lips, causing cold sores, though it increasingly causes genital infections through oral sex. HSV-2 almost exclusively infects the genital area.
The most important practical difference is recurrence. Genital HSV-2 reactivates far more often than genital HSV-1. If you’re diagnosed with genital herpes, knowing which type you have helps predict how often you’ll have outbreaks and how likely you are to transmit the virus to a partner during symptom-free periods.
How HSV-2 Is Diagnosed
If you have active sores, the most reliable test is a PCR swab, which detects the virus’s genetic material directly from the blister fluid or sore. PCR testing for HSV-2 has a sensitivity around 90% and near-perfect specificity, meaning false positives are extremely rare.
If you don’t have active sores, a blood test can check for antibodies your immune system has produced against HSV-2. These antibodies take several weeks to develop after infection, so blood tests done too early can miss a new infection. Blood tests are useful for confirming whether you carry the virus, but they can’t tell you when you were infected or where on the body the virus is active.
Treatment Options
There’s no cure for HSV-2, but antiviral medications reduce the severity and frequency of outbreaks and lower the risk of transmitting the virus to partners. Treatment falls into two categories.
Episodic therapy means taking medication at the first sign of an outbreak to shorten its duration. This works best when started during the prodrome, before blisters fully develop. Treatment courses are short, ranging from one to five days depending on the medication and dosing schedule.
Suppressive therapy means taking a low dose of antiviral medication every day, whether or not you’re having symptoms. Daily suppressive therapy reduces outbreak frequency significantly and also decreases the amount of asymptomatic shedding, which lowers the risk of passing HSV-2 to a sexual partner. People with frequent outbreaks (six or more per year) benefit most from this approach, though anyone with HSV-2 can use it. The most commonly prescribed antivirals are available as pills taken once or twice daily.
Reducing Transmission Risk
Consistent condom use provides significant protection against HSV-2 transmission. A study published in JAMA found that women whose partners used condoms more than half the time had a dramatically lower risk of acquiring HSV-2, with an adjusted risk reduction of about 92% compared to women whose partners rarely used condoms. Protection isn’t absolute because the virus can shed from skin areas a condom doesn’t cover, but the benefit is substantial.
Combining condom use with daily suppressive antiviral therapy provides the strongest protection. Avoiding sexual contact during active outbreaks and prodromal symptoms (tingling, itching, nerve pain) further reduces risk, though asymptomatic shedding means transmission can happen at any time.
HSV-2 and Pregnancy
Newborns can become infected with HSV during pregnancy, during delivery, or shortly after birth. Neonatal herpes is rare but serious, so managing HSV-2 during pregnancy matters. If you have a history of genital herpes, letting your prenatal care provider know early allows for planning.
Women with recurrent genital herpes are typically given antiviral medication during the last month of pregnancy to prevent an outbreak at the time of delivery. If active sores or prodromal symptoms are present when labor begins, a cesarean delivery is recommended to avoid exposing the baby to the virus in the birth canal. The highest risk to the newborn comes from a first-time genital herpes infection during the third trimester, because the mother hasn’t yet developed antibodies that would provide some passive protection to the baby.
HSV-2 and HIV Risk
HSV-2 infection increases the risk of acquiring HIV by two- to threefold. The likely mechanism is that even microscopic breaks in the genital skin from herpes reactivation create entry points for HIV. The inflammatory immune response that HSV-2 triggers in genital tissue also attracts the very immune cells that HIV targets. This connection makes HSV-2 prevention and management especially important in populations with high HIV prevalence.